Spinocerebellar Ataxia Type 5

Neurology·MeSH: Spinocerebellar ataxia, autosomal recessive 3

Prevalence

0.1 / 100K

0 drugs in development·0 companies·1 clinical trial

Frequently asked questions

How many clinical trials target Spinocerebellar Ataxia Type 5?

There are 1 clinical trial targeting Spinocerebellar Ataxia Type 5 tracked by BioSniper.

What is the prevalence of Spinocerebellar Ataxia Type 5?

The estimated prevalence of Spinocerebellar Ataxia Type 5 is approximately 0.1 per 100,000 population.

Deep-dive into Spinocerebellar Ataxia Type 5

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Spinocerebellar Ataxia Type 5 — Drugs in Development & Clinical Trials | BioSniper